Making Decisions about Nurse Practitioners’ Scope of Practice
Dr. David Eddy, founder of
Archimedes, recently visited the
Foundation to present ARCHeS, a Web-based delivery platform that enables
policy-makers and health leaders to use the Archimedes model to run their own
virtual trials. Dr. Eddy demonstrated a prototype version of what users can
expect to access via ARCHeS and previewed new functionality that will allow
providers and decision makers to use the model to tailor care decisions for
individual patients. Pioneer is supporting
Archimedes to build ARCHeS.
What struck me about
ARCHeS was the opportunity it presented to make evidence-based policy decisions
about nurse practitioners’ scope of practice that could potentially result in
significant savings. Currently, those who advocate for nurse practitioners
playing an expanded, autonomous role in delivering primary care point to seminal evidence
showing comparable outcomes in patients randomly assigned to either nurse
practitioners or physicians where nurse practitioners had the same authority,
responsibilities, productivity and administrative requirements, and patient
population as primary care physicians. Though this research is not without its
critics, it has been used successfully to convince many to see nurse
practitioners as part of the solution to expanding access to primary care.
Nevertheless, the debate
around whether and how nurse practitioners’ scope of practice should be
expanded and standardized nationally requires evidence that digs deeper into
aggregate results. Policy makers need access to evidence that elucidates what
nurse practitioners can do as well as physicians vs. tasks/responsibilities that
should be left to physicians.
For example, in his
presentation, Eddy showed how ARCHeS, using evidence about both the cost and
outcomes of nurse practitioners, indicates that having nurse practitioners
administer shots to reduce cholesterol has a striking impact on the cost per QALY for a
treatment option. Funders, including NIH, could use these criteria to
prioritize funding condition/procedure-specific randomized control trials
(RCTs) and other studies.
To learn more about the
implication of ARCHeS, I recommend reading a special report from Business Week entitled “Trimming
Health-Care Costs Without Reforming the System,” which implies that the
Archimedes model, when made accessible to policy makers and other decision
makers, could lead to better decisions that could save billions in health care
costs.